Spectrum Pharmaceuticals, Inc. Added to the Russell Global(R), Russell 3000(R) and Russell 2000(R) Indexes

IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced that Russell Investments has added Spectrum Pharmaceuticals to the Russell Global®, the Russell 3000® and the Russell 2000® Indexes. Russell Investments produces a family of market cap-weighted U.S. equity indexes. All U.S. indexes are subsets of the Russell 3000E™ Index, which represents approximately 99% of the U.S. equity market.